Archives
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Acetylcysteine in Precision Disease Modeling: Beyond Tumo...
2025-10-18
Explore how Acetylcysteine (N-acetyl-L-cysteine, NAC) enables next-generation research into glutathione biosynthesis and oxidative stress modulation. This article uniquely examines its role in precision disease modeling, integrating advanced mechanistic insights and translational applications.
-
Strategic Substrate Engineering: How Equimolar dNTP Mixtu...
2025-10-17
Explore the convergence of DNA synthesis precision and nucleic acid delivery optimization through the lens of the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture. This thought-leadership article provides mechanistic insights, evidence from recent lipid nanoparticle (LNP) trafficking studies, and strategic guidance for translational researchers leveraging molecular biology reagents for next-generation therapeutics.
-
AP20187: Empowering Translational Researchers with Precis...
2025-10-16
Explore the next frontier in translational research with AP20187—a synthetic, cell-permeable dimerizer that unlocks unprecedented control over fusion protein signaling. This thought-leadership article delves into the mechanistic rationale for chemical inducers of dimerization, highlights AP20187’s unique advantages for gene expression control in vivo, and connects recent discoveries in 14-3-3 protein signaling to emerging clinical and therapeutic paradigms. Discover how AP20187 is redefining the toolkit for regulated cell therapy, hematopoietic expansion, and metabolic pathway modulation, and gain actionable insights for moving from bench to bedside.
-
Our findings establish a critical link
2024-12-02

Our findings establish a critical link between HemAC-Lm dimeric structure and cAMP synthesis that helps in explaining how globin-A domain influences AC domain. The following possible homodimeric structure of wild type full length HemAC-Lm has been proposed to explain the role of this globin-A domain
-
Finally one can ask whether these results
2024-12-02

Finally, one can ask whether these results throw any light on the nature of the target in SNMG patients. Interestingly, the results of the in vitro incubations suggested that SNMG sera might increase AChR expression to a small extent, raising the possibility that SNMG patients, who have thymic chang
-
The role of DHT in
2024-12-02

The role of DHT in early teleost embryogenesis is not entirely clear or established, however additional studies that treat fish embryos to DHT or to specific srd5a inhibitors at critical stages of development (i.e. prior to sex differentiation) will shed light on the early functions of this androgen
-
Despite the growing knowledge surrounding the link between A
2024-12-02

Despite the growing knowledge surrounding the link between ATX and cholestatic pruritus in PBC, it remains unclear if the role of the ATX-LPA signaling axis includes lymphocytes homing in the liver of PBC, and if the resulting inflammation is associated with PBC pruritus (Fig. 3). PBC is characteriz
-
br Breast cancer The interactions between LOX and
2024-12-02

Breast cancer The interactions between 15-LOX and COX enzymes also affect the outcome of breast cancer. Indomethacin, a COX-1 and COX-2 inhibitor, decreased the growth of human breast cancer (BC) cells in nude mice, as well as slowed the rate of lung metastasis formation [41]. The levels of 12-HE
-
br Regulatory mechanisms of ASK activity br
2024-12-02

Regulatory mechanisms of ASK1 activity The functions of ASK1 in disease ASK1 inhibitor As mentioned above, ASK1 plays a pivotal role in the pathogenesis of various diseases; hence, an ASK1 inhibitor has therapeutic potential. Although inhibitors of the ASK1 downstream kinases p38 and JNK ar
-
The presence of crown like structures and inflammatory facto
2024-12-02

The presence of crown-like structures and inflammatory factors in the breast of obese patients is associated with considerable changes in intracellular signaling and a profound cellular dysfunction. Secreted pro-inflammatory factors can directly promote breast carcinogenesis as they have been report
-
The Limitations of our data include
2024-12-02

The Limitations of our data include the absence of functional/behavioral assessments and lack of direct comparison with females which would require additional studies and conceivably support sex-specific interventions for stroke [50]. Competing interests Acknowledgements This study was suppor
-
Acknowledgments br Introduction Pulmonary fibrosis PF
2024-12-02

Acknowledgments Introduction Pulmonary fibrosis (PF) is a chronic, fibrosing interstitial pneumonia and a crushing disease that occurs as a result of a variety of lung injuries, including auto-immune, tuberculosis and traumatic insult [1], [2]. PF is characterized by the accumulation of extracel
-
In the present study a splice
2024-12-02

In the present study, a splice acceptor site mutation (c.1769-1G > C) was identified in AR gene from patients with CAIS. The c.1769-1G > C mutation results in replacement of the normal sequence (CAG/G) with a new sequence (CAC/G) at the splice acceptor site of intron 2. In the splice acceptor site r
-
Based on their different sources the APN
2024-11-29

Based on their different sources, the APN inhibitors (APNIs) can be divided into the natural products and synthetic compounds. Bestatin (1, Fig. 1), isolated from the Streptomyces oliuoreticuli by Umezawa et al., is the first reported and only marketed natural dipeptidomimetic inhibitor of APN. Afte
-
Decrease in soluble protein content in diabetic lenses compa
2024-11-29

Decrease in soluble protein content in diabetic lenses compared with those in control lenses in present study could be due to leakage of proteins and insolubilization. T. purpurea treatment could increase the levels of soluble proteins in diabetic lenses may be by preventing cross-linking/aggregatio
14366 records 6/958 page Previous Next First page 上5页 678910 下5页 Last page